Clinical Trial

Characterisation of Endothelial Cells in Different Inflammatory Pathologies

Study acronym: JEDI-2
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 25, 2024 (before its estimated July 17, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to characterise changes in gene expression in endothelial cells in patients with either sepsis or post major abdominal surgery. The main question we plan to answer is: 'What molecular pathways are differentially expressed during inflammatory pathologies?'
Trial Details
NCT Number NCT06613256
Lead Sponsor Royal Surrey County Hospital NHS Foundation Trust
Collaborators: University of Surrey
Conditions Sepsis, Vasoplegia
Enrollment 105 participants
Start Date 2024-07-16
Primary Completion 2026-07-17 (estimated)
Study Completion 2026-11-12 (estimated)
Updated on ClinicalTrials.gov 2024-09-25